Programa International Review of Bipolar Disorders Sevilla 2013 Más información en www.puedoser.es

1. The 13th International Review of
Bipolar Disorders
18 - 20 March 2013 NH Hotel Convention Centre, Seville, Spain
www.irbd.org
Day 1 - Monday 18 March 2013 - Draft Programme
Theme: Categories & Dimensions -
Temperament, Spectrum and Associated Issues
Key: MS = Multiple, KN = Keynote, DB = Debate, OP = Oral Platform, PO = Posters, PS = Parallel Session
09.00 Registration Opens (open for duration of conference)
Morning plenary sessions - Gran Salón Andalucía
09.15 Pre-conference Workshop: Introduction to Impulsivity
(in association with International Society for Research on Impulsivity)
Chair: Prof A Swann (US)
Impulsivity: Its measurement and its relationship to clinical phenomena
Prof A Swann (US)
Brain mechanisms of impulsivity and relationships to risky behaviour
Dr L Mason (UK)/Prof R Rogers (UK)
Practical aspects: Relationships to outcome, nonpharmacological and pharmacological treatments
Prof J Scott (UK)/Prof E Jimenez (ES)
11.15 Refreshments - Vestíbulo, Salón Malaga & Salón Marbella
11.45 IRBD 2013 Welcome and Introduction
Conference Chairman: Prof E Vieta (ES)
EBF Director: Mr R Pendleton (UK)
12.00 MS1: European Bipolar Forum: Affective temperament
Chair: Prof J Angst (CH)
Bipolarity in patients with borderline personality disorders: What is
specific and non-specific?
Prof G Perugi (IT)
Borderline in Cyclothymia, the role of irritable temperament
Dr E Hantouche (FR)
Prediction of suicidality in the community: The role of temperament
Prof E Karam (LB)
13.30 Lunch and Poster session (PO1) - Vestíbulo, Salón Malaga & Salón Marbella
14.30 PS1: Temperaments as mediators of suicide risk, PS2: Evolutionary aspects of bipolar disorders
hopelessness and psychopathology in bipolar and affective temperaments (Salón Alanda)
disorders (Gran Salón Andalucía) Dr X Gonda (HU)
Prof M Pompili (IT)
A Cortex Congress Conference PROGRAMME CO-CHAIRS

2. The 13th International Review of
Bipolar Disorders
18 - 20 March 2013 NH Hotel Convention Centre, Seville, Spain
www.irbd.org
Day 1 - Monday 18 March 2013 (Cont’d)
Theme: Categories & Dimensions - Temperament, Spectrum and Associated Issues
Key: MS = Multiple, KN = Keynote, DB = Debate, OP = Oral Platform, PO = Posters, PS = Parallel Session
15.00 MS2: Neurobiological markers in MS3: Youth temperament and affective disorders
bipolar illness (Gran Salón Andalucía) (Salón Alanda)
Chair: Prof J K Rybakowski (PL) Chair: Prof M L Figueira (PT)
Biological markers of staging in bipolar illness Youth suicide attempts
Prof F Kapczinski (BR) Prof M L Figueira (PT)
GSK-3beta and beta-catenin in the postmortem The prodromal phase of bipolar disorder
brain of bipolar and schizophrenic subjects Prof G Faedda (US)
Prof G Pandey (US) Advances in assessment: fast and frugal
The HPA Axis and cognition in bipolar disorder methods of detection without over diagnosis
Prof A Young (UK) Prof E Youngstrom (US)
Clinical and biological markers of lithium response Delayed sleep offset and other markers of circadian
Prof J K Rybakowski (PL) rhythm disruption are common in young people with
emerging mood disorders
Prof I Hickie (AU)
17.00 Refreshments - Vestíbulo, Salón Malaga & Salón Marbella
17.30 MS4: Clinical staging: Understanding the evolu- MS5: The impact of co-morbidities on Bipolar
tion of bipolar disorders and defining treat- Chair: Prof G Perugi (IT) (Salón Alanda)
ments for at risk and early onset cases
Chair: Prof J Scott (UK) (Gran Salón Andalucía) Obesity & bipolar disorder
Prof A Tortorella (IT)
Clinical staging models for bipolar disorders:
Understanding different approaches to staging Affective temperament and
Prof J Scott (UK) smoking
Prof Z Rihmer (HU)
An evidence map of psychosocial interventions for
‘at risk’, first episode and early onset bipolar The impact of comorbidities of bipolar disorder -
disorders Alcohol, temperament and bipolar disorder
Dr M Vallarino (IT) Prof A Erfurth (AT)
What do offspring studies teach us about clinical Comorbidity and functioning
staging models for bipolar disorders? Dr L Gutierrez-Rojas (ES)
Prof A Duffy (CA)
Bipolar spectrum and heroin
Examining the evidence for pharmacological addiction - tendency to abuse or self-medication?
treatments in recent onset bipolar disorder? Prof I Maremmani (IT)
Prof F Bellivier (FR)
19.30 DB1: What comes first? High level of impulsiveness or mood instability?
Chair: Prof K Fountoulakis (GR) (Gran Salón Andalucía)
Argument for impulsiveness
Prof A Swann (US)
Argument for mood instability
Prof Z Rihmer (HU)
Discussion: Prof K Fountoulakis (GR)
20.30 CLOSE of Day 1 and Welcome Reception
21.30 EBF International Scientific Advisory Committee Dinner
IRBD 2014 Programming meeting
A Cortex Congress Conference PROGRAMME CO-CHAIRS

3. The 13th International Review of
Bipolar Disorders
18 - 20 March 2013 NH Hotel Convention Centre, Seville, Spain
www.irbd.org
Day 2 - Tuesday 19 March 2013 - Draft Programme
Theme: Changing Clinical Concepts -
Re-definitions, New Treatments & Evolution
Key: MS = Multiple, KN = Keynote, DB = Debate, OP = Oral Platform, PO = Posters, PS = Parallel Session
09.00 MS6: Cognition and Bipolar Disorders PS3: Trauma and bipolar disorder
Chair: Prof A Erfurth (AT) (Gran Salón Andalucía) Chair: Dr G Faedda (US)
Dr B Amann (ES)
The assessment and treatment of cognitive
deficits in bipolar disorder
Prof A Martinez-Aran (ES) PS4: Antidepressant use in Bipolar disorder II
The burden of cognitive dysfunction Chair: Dr G Faedda (US)
Prof G Sachs (AT) Dr J Undurraga (ES)
10.00 Refreshments - Vestíbulo, Salón Malaga & Salón Marbella
10.30 The Paradigm Shift in Bipolar I Disorder (Lundbeck sponsored symposium)
Chair - Prof E Vieta (ES) (Gran Salón Andalucía)
Introducing clinically relevant subtypes in DSM-V
Prof J van Os (NL)
Managing the core manic symptoms and the depressive features in manic bipolar I
Prof H Grunze (UK)
Customised treatment of bipolar I patients
Prof A Young (UK)
Assertive treatment of bipolar I (remission and beyond)
Prof E Vieta (ES)
General discussion
12.30 KN1: Bipolar and anxiety disorders: Comorbidity and validity of episode length
Prof J Angst (CH) (Gran Salón Andalucía)
13.00 Lunch and Poster session (PO2) - Vestíbulo, Salón Malaga & Salón Marbella
Afternoon plenary sessions - Gran Salón Andalucía
14.00 Patient and physician perspectives in bipolar disorder (AstraZeneca sponsored symposium)
Chair - Prof E Vieta (ES)
Treatment approaches in bipolar disorder
Prof A Young (UK)
Evidence and issues in the real world
Prof E Vieta (ES)
Maximising patient outcomes: Bringing together perspectives
Prof H McAllister-Williams (UK)
Panel discussion
A Cortex Congress Conference PROGRAMME CO-CHAIRS

4. The 13th International Review of
Bipolar Disorders
18 - 20 March 2013 NH Hotel Convention Centre, Seville, Spain
www.irbd.org
Day 2 - Tuesday 19 March 2013 - Draft Programme - Cont
Theme: Changing Clinical Concepts -
Re-definitions, New Treatments & Evolution
Key: MS = Multiple, KN = Keynote, DB = Debate, OP = Oral Platform, PO = Posters, PS = Parallel Session
16.00 Refreshments - Vestíbulo, Salón Malaga & Salón Marbella
16.30 MS7: Recent advances in the short-term treatment of bipolar depression
Chair: Prof J Calabrese (US)
Morbidity and mortality associated with bipolar depression
Prof T Ketter (US)
Short-term studies in bipolar depression using adjunctive designs
Prof J Calabrese (US)
Linking neurotransmitter receptors to novel mechanisms of therapeutic action and side-effect profiles
Dr J Goikolea (ES)
18.00 MS8: Understanding the long-term perspective and options to help achieve long-term remission
Chair: Prof K Fountoulakis (GR)
Bipolar depression and interepisodal symptomatology
Prof A González-Pinto (ES)
Psychosocial interventions and physical care
Dr C Torrent (ES)
Refractoriness in bipolar disorder: Definitions and evidence-based treatment
Prof K Fountoulakis (GR)
19.30 CLOSE Day 2
20.30 Gala Dinner and Presentation of EBF Lifetime Achievement Award
A Cortex Congress Conference PROGRAMME CO-CHAIRS

5. The 13th International Review of
Bipolar Disorders
18 - 20 March 2013 NH Hotel Convention Centre, Seville, Spain
www.irbd.org
Day 3 - Wednesday 20 March 2013 - Draft Programme
Theme: Understanding Disease Progression -
Advanced Diagnostics & Care, Today & Tomorrow
Key: MS = Multiple, KN = Keynote, DB = Debate, OP = Oral Platform, PO = Posters, PS = Parallel Session
Morning plenary sessions - Gran Salón Andalucía
09.00 KN2: Functional imaging abnormality in bipolar disorder: What changes and what doesn’t change
across phases
Chair:
Dr P McKenna (ES)
09.30 KN3: Pharmacogenetics and personalized pharmacology of bipolar disorder
Chair: Prof J Del Tito (US)
Prof J Kelsoe (US)
10.00 MS9: Marking a border between bipolar and unipolar disorders
Chair: Dr A Murru (ES)
Risks and advantages of the use of antidepressants in bipolar depression
Prof L Tondo (IT)
Unipolar and bipolar schizoaffective disorders: diagnostic residuals or clinical entities?
Dr A Murru (ES)
11.00 Refreshments - Vestíbulo, Salón Malaga & Salón Marbella
11.30 PS5: When first line treatment will not suffice OP: Oral Platform sessions
Chair: Prof J Cookson (UK) Chair:
(Gran Salón Andalucía) (Salón Alanda)
The use of residential treatment for children and Affective temperaments in the Tunisian general
adolescents with bipolar disorder and psychological Population - Dr R Zaibi Jomli
resistance to it Mixed hypomania with psychotic features congruent
Prof R Bush (US) for the depressed phase - Prof S Dilsaver
Let’s face it: facial emotion processing is impaired in
The severe part of the bipolar II spectrum: Border-
bipolar disorder - Miss T Van Rheenen
line personality and more persistant
Mental imagery: an emotional amplifier for bipolar dis-
psychopathology
order? - Dr R MK Ng
Prof J Deltito (US)
Proposals for new paths to bipolarity, mixity,
Factors associated with adherence to medication in fibromyalgia and migraine - Dr G Treviranus
a French cohort (FACE-BD) of bipolar patients Could glutamate spectroscopy differentiate bipolar
Prof R Belzeaux (FR) depression from unipolar? - Dr M Taylor
Prestige and bipolarity: An evolutionary perspective -
Dr J Le Bas
13.00 KN4: Depot antipsychotic medication in bipolar disorder
Prof J Cookson (UK) (Gran Salón Andalucía)
13.30 Closing Address and Close of Conference
A Cortex Congress Conference PROGRAMME CO-CHAIRS